Directed evolution of bacteriorhodopsin for applications in bioelectronics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23676894.
- Also identified by DOI 10.1098/rsif.2013.0197 and PMC identifier 3673155.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In nature, biological systems gradually evolve through complex, algorithmic processes involving mutation and differential selection. Evolution has optimized biological macromolecules for a variety of functions to provide a comparative advantage. However, nature does not optimize molecules for use in human-made devices, as it would gain no survival advantage in such cooperation. Recent advancements in genetic engineering, most notably directed evolution, have allowed for the stepwise manipulation of the properties of living organisms, promoting the expansion of protein-based devices in nanotechnology. In this review, we highlight the use of directed evolution to optimize photoactive proteins, with an emphasis on bacteriorhodopsin (BR), for device applications. BR, a highly stable light-activated proton pump, has shown great promise in three-dimensional optical memories, real-time holographic processors and artificial retinas.
Medical subject headings
- Bacteriorhodopsins
- Bioengineering
- Directed Molecular Evolution
- Electronics, Medical
- Nanotechnology